Knowledge Center
Patent / Jan 01, 2013
Application of high dose compounds via inhalation for treatment of pulmonary diseases
Source:
WO 2013104892
The invention relates to the delivery of high doses of active pharmaceutical compds. via inhalation for the treatment of pulmonary diseases. A pharmaceutical formulation in the form of a powder suitable for inhalation comprises one or more active pharmaceutical ingredients, such as an antibiotic, a mucolytic agent and/or a buffer, wherein the formulation is free of carrier. A powder formulation comprising doxycycline monohydrate combined with sodium citrate filled into TwinCap devices was exemplified.
Also in the Knowledge Center
/ Mar 01, 2023
Framework for the validation of mechanistic and hybrid models as Process Analytical tools in the pharmaceutical Industry
Read more
Scientific Article
Scientific Article
/ Aug 03, 2023
Nasal-PAMPA: A novel non-cell-based high throughput screening assay for prediction of nasal drug permeability
Read more
Scientific Article